![Galea Life Science](/news-release/logo/216833/0/216833.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A50&size=2)
Galea Life Sciences, Inc. Accepts Settlement and Prepares New Form 10 Registration Statement
October 09, 2008 08:00 ET
|
Galea Life Sciences
MIAMI, Oct. 9, 2008 (GLOBE NEWSWIRE) -- Galea Life Sciences Inc. (Pink Sheets:GLSN) announced today that the company has accepted an offer of settlement with the U.S. Securities and Exchange...
![Galea Life Science](/news-release/logo/216833/0/216833.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A50&size=2)
Galea Life Sciences' Subsidiary Awarded Presentation Slot for Clinical Policy Abstract At 15th International Symposium on HIV and Emerging Infectious Diseases
April 01, 2008 09:00 ET
|
Galea Life Sciences
MIAMI, April 1, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announced that its BioSource Therapeutics, Inc. (BST) subsidiary will present its clinical policy abstract...
![Galea Life Science](/news-release/logo/216833/0/216833.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A50&size=2)
Galea Life Sciences, Inc. Completes Financing
March 06, 2008 11:16 ET
|
Galea Life Sciences
MIAMI, March 6, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN), whose BioSource Therapeutics, Inc. (BST) subsidiary manufactures and markets Nutraplete(tm) Therapeutic Drink...
![Galea Life Science](/news-release/logo/216833/0/216833.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A50&size=2)
Nutraplete Featured in AIDS Institute's Action Link Journal Article
March 04, 2008 09:00 ET
|
Galea Life Sciences
MIAMI, March 4, 2008 (PRIME NEWSWIRE) -- Nutraplete, the flagship product of BioSource Therapeutics (BST), is to be featured in the March 2008 edition of the Action Link Journal. The Action Link...
![Galea Life Science](/news-release/logo/216833/0/216833.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A50&size=2)
Galea Life Sciences' BioSource Therapeutics, Inc. Subsidiary Names Edward Martin to its Board of Directors
February 13, 2008 11:16 ET
|
Galea Life Sciences
MIAMI, Feb. 13, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announces that its wholly-owned subsidiary, BioSource Therapeutics, Inc. (BST), has named Edward Martin to its...
![Galea Life Science](/news-release/logo/216833/0/216833.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A50&size=2)
Galea Life Sciences' BioSource Therapeutics, Inc. Subsidiary Submits Clinical Policy Abstract to 17th International AIDS Conference
February 07, 2008 09:03 ET
|
Galea Life Sciences
MIAMI, Feb. 7, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announces that its wholly owned subsidiary, BioSource Therapeutics, Inc. (BST), has submitted its clinical policy...
![Galea Life Science](/news-release/logo/216833/0/216833.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A50&size=2)
Dr. Terence M. Dolak, Ph.D. Named Chief Scientific Advisor for Galea Life Sciences' BioSource Therapeutics, Inc. Subsidiary
January 24, 2008 12:06 ET
|
Galea Life Sciences
MIAMI, Jan. 24, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announced today that BioSource Therapeutics, Inc. (BST), its wholly-owned subsidiary, has named Dr. Terence M....
![Galea Life Science](/news-release/logo/216833/0/216833.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A50&size=2)
Dr. Robert Keller, MD, Named Head of Scientific Advisory Board for Galea Life Sciences' BioSource Therapeutics, Inc. Subsidiary
December 18, 2007 08:17 ET
|
Galea Life Sciences
MIAMI, Dec. 18, 2007 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announced today that BioSource Therapeutics, Inc. (BST), its wholly-owned subsidiary, has named Dr. Robert Keller,...
![Galea Life Science](/news-release/logo/216833/0/216833.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A50&size=2)
Galea Life Sciences, Inc. Retains Hogan & Hartson LLP
December 13, 2007 08:54 ET
|
Galea Life Sciences
MIAMI, Dec. 13, 2007 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink sheets:GLSN) today announced that it has retained Hogan & Hartson LLP in connection with obtaining necessary approvals for...
![Galea Life Science](/news-release/logo/216833/0/216833.jpg?lastModified=12%2F09%2F2016%2022%3A46%3A50&size=2)
BioSource Therapeutics' CEO David Miller Presents At Global Summit On AIDS and the Church At Saddleback Church
November 30, 2007 11:09 ET
|
Galea Life Sciences
MIAMI, Nov. 30, 2007 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) today announced that David Miller, CEO of its BioSource Therapeutics, Inc. (BST) subsidiary, was a keynote speaker...